ARCHIVES

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

This article is from The Cancer Letter archive.

Vol. 11 No. 10 | March 8, 1985

Download PDF Visit The Full Archive

Related Articles

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship

December 11, 1992

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011